Samuel Deutsch

Samuel Deutsch

Company: Nutcracker Therapeutics

Job title: CSO

Seminars:

Harnessing mRNA Therapeutic Platforms to Accelerate Product Development 2:15 pm

Describing different platform components from design to manufacturing, and their importance to accelerating product development Leveraging critical elements in protein and mRNA design to drive clinically relevant PK and purity behaviours in vivo Transitioning from in vitro to rodents to non-human primates to best predict clinical efficacy in heterogeneous populationsRead more

day: Day One Track A PM

Developing Next Generation Delivery Vehicles to Improve Translational Potential

Chair Moderation: 11:12 am

Read more

day: Day Two Track (TRANSLATIONAL DEVELOPMENT TRACK)

TRANSLATIONAL DEVELOPMENT TRACK

Chair Moderation: 10:05 am

Read more

day: Day One Track A AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.